BSECompany Update4d ago · 14 Nov 2026, 08:31 pm
Pursuant to Regulation 32 of the Securities and Exchange Board of India ("SEBI") (LODR) Regulations, 2015 along with 173A of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, we have enclosed herewith the Monitoring Agency Report for the quarter ended September 30, 2026, issued by Crisil Ratings Limited , in respect of the utilization of proceeds raised through Preferential Issue by the Company, duly reviewed by the Audit Committee ....
ZR2 Bioenergy Ltd · 506640
✦ AI SummaryRegulatory
ZR2 Bioenergy Ltd has submitted a Monitoring Agency Report for the quarter ended September 30, 2026, issued by Crisil Ratings Limited, in respect of the utilization of proceeds raised through Preferential Issue. The report highlights a deviation from the prevailing industry practice of investing unutilized proceeds in low-risk liquid instruments, as the company has deployed unutilized issue proceeds of Rs 18.50 crore through a short-term deposit arrangement with M/s Sukhmehar Finance Private Limited.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern6/10
Regulatory Risk8/10
Balance Sheet Risk4/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
ZR2 Bioenergy Ltd - 506640 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Attachments (1)
📄pdf
Download →
89a5ce12-0f26-42ff-9988-1f9829947395.pdf
View document text
November 14, 2026
BSE Limited,
P.J. Towers, Dalal Street,
Mumbai – 400 001.
Dear Sir / Madam,
Scrip Code : 506640
Sub : Monitoring Agency Report for the quarter ended September 30, 2026.
Pursuant to Regulation 32 of the Securities and Exchange Board of India ("SEBI") (Listing Obligations and
Disclosure Requirements) Regulations, 2015 ("Listing Regulations") read with Regulation 173A of SEBI
(Issue of Capital and Disclosure Requirements) Regulations, 2018, we have enclosed herewith the
Monitoring Agency Report for the quarter ended September 30, 2026, issued by Crisil Ratings Limited
("Monitoring Agency"), in respect of the utilization of proceeds raised through Preferential Issue by the
Company, duly reviewed by the Audit Committee and taken on record by the Board of Directors.
We request you to kindly take these submissions on your record and disseminate the same.
For ZR2 Bioenergy Limited
(Formerly known as Gujchem Distillers India Limited)
Jimmy Olsson
Managing Director
Registered Office: 307 Ashirwad Paras – 1, S.G. Highway, Makarba, Ahmedabad 380 051
Corporate Office: 1102 Lodha Supremus, Senapati Bapat Marg, Mumbai, 400 013
Tel: +91 83560 34700 Email: CIN No:L32909GJ1939PLC002480
Monitoring Agency Report
ZR2 BIOENERGY LIMITED
(formerly known as Gujchem Distillers
India Limited)
for the quarter ended
September 30, 2026
CRL/MAR/GDS6823/2026-27/2098
November 14, 2026
ZR2 Bioenergy Limited (Formerly known as Gujchem Distillers India Limited)
307, Third Floor, Ashirwad Paras-1, Kanti Bharwad PMT,
Opposite Andaz Party Plot, Makarba,
Ahmedabad, Gujarat, 380051
Dear Sir,
Sub: Monitoring Agency Report for the quarter ended September 30, 2026 – in relation to the Preferential
Issue of ZR2 Bioenergy Limited (Formerly known as Gujchem Distillers India Limited) (“the Company”)
Pursuant to Regulation 162A of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 (“ICDR
Regulations”) and Monitoring Agency Agreement dated October 25, 2024, entered with the Company, we enclose
the Monitoring Agency Report, issued by Crisil Ratings Limited, as per Schedule XI of the SEBI ICDR Regulations
towards utilization of proceeds of Preferential Issue for the quarter ended September 30, 2026.
Request you to kindly take the same on records.
Thanking you,
For and on behalf of Crisil Ratings Limited
Shounak Chakravarty
Director, Ratings (LCG)
Report of the Monitoring Agency (MA)
Name of the issuer: ZR2 BIOENERGY LIMITED (formerly known as Gujchem Distillers India Limited)
For quarter ended: September 30, 2026
Name of the Monitoring Agency: Crisil Ratings Limited
(a) Deviation from the objects: Not applicable. Refer qualification/observations mentioned below.
(b) Range of Deviation: Not applicable
Qualification: The Company's shareholders notice dated May 16, 2024 did not disclose the mode of deployment of unutilized proceeds, as
required under BSE Notice No. 20221213-47 dated December 13, 2022. However, during the quarter ended December 31, 2024, the Company
deployed unutilized issue proceeds of Rs 18.50 crore through a short-term deposit arrangement with M/s Sukhmehar Finance Private Limited.
As per the RBI's list of registered NBFCs as of December 31, 2024 and June 30, 2026, M/s Sukhmehar Finance Private Limited is a non-
deposit taking NBFC.
The aforesaid deployment is in variation from the prevailing industry practice of investing unutilized proceeds in low-risk liquid instruments
such as fixed deposits with scheduled commercial banks or low risk mutual funds. While the arrangement was approved by the Board on
December 18, 2024 to invest in short-term deposit, the deployment has continued for over 21 months as of September 2026, and no subsequent
Board resolution expressly approving the continuation of the deployment of unutilized issue proceeds with Sukhmehar Finance Private
Limited has been provided to the Monitoring Agency. However, the Company has provided a resolution dated May 15, 2026, whereby -"the
Board of directors of the Company has approved an extension of 12 (twelve) months from the date of the resolution for the utilization of the
balance issue proceeds aggregating to Rs. 18.50 crore (Rupees Eighteen Crore and Fifty Lakhs Only), currently deployed with Sukhmehar
Finance Private Limited.
This is to bring to the attention of the stakeholders that the said deployment may have implications for the future availability of funds for
utilization towards the stated objects of the issue.
Further details are provided under the head "Deployment of Unutilized Issue Proceeds" on page 8 of the Monitoring Agency Report.
Declaration:
We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the
information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform
an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to
create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said
information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner
whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and
any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section
2(38) of the Companies Act, 2013.
The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive
separate compensation for its ratings and certain credit-related analyses. We confirm that we do not perceive any conflict of interest in such
relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer.
We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are
certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management /
Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report
through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the
issuer’s Management/Board.
Signature:
Name and designation of the Authorized Signatory: Shounak Chakravarty
Designation of Authorized person/Signing Authority: Director, Ratings (LCG)
1) Issuer Details:
Name of the issuer: ZR2 BIOENERGY LIMITED
Names of the promoter: ZR2 Group Holdings Limited
Industry/sector to which it belongs: Commodity Chemicals
2) Issue Details
Issue Period: 13 August 2024
Type of issue: Preferential Issue
Type of specified securities: Compulsory Convertible Debentures (hereon referred as
“CCDs”) & Convertible warrants
Issue Grading, if any: NA
Issue size: Total issue proceeds* amounting to Rs. 248.77 crore (Refer Note 4
given in page no. 7)
*Crisil Ratings shall be monitoring the total issue proceeds as per the notice to shareholder dated May 16, 2024
3) Details of the arrangement made to ensure the monitoring of issue proceeds:
Source of information / Comments
certifications considered Comments of the of the
Particulars Reply
by Monitoring Agency for Monitoring Agency Board of
preparation of report Directors
Bank Statement,
Notice to shareholder
No utilisation
(hereinafter referred as
Whether all utilization is as per the reported during the No
Yes “Offer document”),
disclosures in the offer document? quarter ended Comments
Management Undertaking,
September 30, 2026
Statutory Auditor’s
Certificate^
Whether shareholder approval has been
obtained in case of material deviations#
[Showing first 8,000 characters — download PDF for full document]